News for 'US Food and Drug Administration'

US nod for Ranbaxy's AIDS drug

US nod for Ranbaxy's AIDS drug

Rediff.com1 Jun 2005

Tamil Nadu film producer, who was expelled by DMK, held in drugs case

Tamil Nadu film producer, who was expelled by DMK, held in drugs case

Rediff.com9 Mar 2024

The Narcotics Control Bureau (NCB) on Saturday said it has arrested Jaffer Sadiq, a Tamil Nadu-based alleged dealer of narcotics, in connection with an international drugs trafficking investigation case.

Sun gets nod to sell anti-anxiety drug in US

Sun gets nod to sell anti-anxiety drug in US

Rediff.com18 Jun 2010

Sun Pharmaceutical Industries on Friday said that it has received the US Food and Drug Administration's nod to market a generic version of alprazolam, an anti-anxiety drug, in the US market.

War on made-in-India drugs comes to US Capitol Hill

War on made-in-India drugs comes to US Capitol Hill

Rediff.com20 Mar 2014

Whistle-blower Dinesh Thakur tells briefing on US Capitol Hill: 'One in five medicines manufactured and distributed in India are spurious.' Aziz Haniffa reports from Washington, DC.

Ranbaxy gets USFDA nod for AIDS drug

Ranbaxy gets USFDA nod for AIDS drug

Rediff.com28 May 2005

Ranbaxy Laboratories has received tentative approval from the US Food and Drug Administration to manufacture and market Lamivudine Tablets in 150 mg strength, the company announced on Saturday.

Mumbai hospitals await FDA guidance on Ranbaxy drugs

Mumbai hospitals await FDA guidance on Ranbaxy drugs

Rediff.com10 Jun 2013

Earlier, Jaslok Hospital had issued an advisory to its doctors to avoid prescribing drugs manufactured by Ranbaxy.

Ranbaxy's diabetes drug gets US FDA nod

Ranbaxy's diabetes drug gets US FDA nod

Rediff.com22 Jun 2004

Ranbaxy on Tuesday announced it had got final approval from the US Food and Drug Administration to market its Metformin HC1 tablets for diabetes.

Equity market volatility may persist; long-term outlook remains constructive: Experts

Equity market volatility may persist; long-term outlook remains constructive: Experts

Rediff.com3 Apr 2025

The heightened global uncertainty due to the US "reciprocal tariffs" on India may cause near-term corrections and market turbulence, but the long-term outlook remains constructive, market experts said on Thursday. The US has announced 27 per cent reciprocal tariffs on India, citing high import duties imposed by New Delhi on American goods.

Glenmark gets USFDA nod for drug

Glenmark gets USFDA nod for drug

Rediff.com19 Jun 2013

Riluzole is indicated for the treatment of amyotrophic lateral sclerosis.

Ranbaxy gets tentative FDA nod for drug

Ranbaxy gets tentative FDA nod for drug

Rediff.com21 Jul 2005

Ranbaxy Laboratories Ltd today said it has received tentative approval from the US Food and Drug Administration to manufacture and market Glimepiride tablets of 1 mg, 2 mg, 4 mg and 8 mg.

The Coming Dementia Epidemic

The Coming Dementia Epidemic

Rediff.com20 Dec 2024

Around 7.4 per cent of Indians aged 60 and above are affected by dementia. This number is expected to rise from the current 8.8 million to 17 million by 2036, marking a 97 per cent increase.

Ranbaxy gets US FDA approval for drug

Ranbaxy gets US FDA approval for drug

Rediff.com16 Sep 2003

Ranbaxy Laboratories on Tuesday said it had received approval from US Food and Drug Administration to market a semi synthetic cephalosporin Panixine DisperDose, a generic version of Ceph International Corp, Keflex.

Sun Pharma US arm told to recall diabetes drug

Sun Pharma US arm told to recall diabetes drug

Rediff.com25 Mar 2008

The US Food and Drug Administration (USFDA) has asked Caraco Pharmaceutical Laboratories, the US subsidiary of Mumbai-based Sun Pharmaceuticals Industries, to withdraw many batches of its generic Metformin Hydrochloride tablets used for treating diabetes, citing efficacy and quality issues. According to a USFDA Class II withdrawal announced on March 19, Caraco will have to withdraw seven lots of Metformin Hydrochloride in bottles of 100, 500 and 1000 tablets each.

Ranbaxy gets final FDA nod for drug

Ranbaxy gets final FDA nod for drug

Rediff.com10 Jun 2004

Ranbaxy Laboratories on Thursday said that it had received final approval from US Food and Drug Administration to manufacture and market Ciprofloxacin.

Scientists identify 70 drugs that may fight COVID-19

Scientists identify 70 drugs that may fight COVID-19

Rediff.com26 Mar 2020

The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains, according to the researchers.

Dr Reddy's launch generic cancer drug in US market

Dr Reddy's launch generic cancer drug in US market

Rediff.com12 Jul 2013

The company has launched the Decitabine for injection in the strength of 50 mg in the US market following approval by the United States Food & Drug Administration of Dr Reddy's abbreviated new drug applications, it said in a statement.

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Rediff.com8 Nov 2022

A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.

FSSAI launches probe into MDH and Everest products

FSSAI launches probe into MDH and Everest products

Rediff.com23 Apr 2024

The Food Safety and Standards Authority of India (FSSAI) has commissioned a quality check on MDH and Everest products. This follows complaints that several popular spice mixes of the two leading brands contained traces of ethylene oxide more than the permissible levels, official sources said. This move by FSSAI comes after Hong Kong and Singapore recalled variants of the two masala majors' products in their countries.

Prescription drugs still available online

Prescription drugs still available online

Rediff.com4 May 2015

The FDA Maharashtra on Friday lodged an FIR against Snapdeal.

Lupin launches generic GERD drug in the US market

Lupin launches generic GERD drug in the US market

Rediff.com11 Nov 2013

The company's US-based subsidiary Lupin Pharmaceuticals Inc has launched its generic Rabeprazole Sodium delayed-release tablets, 20 mg in the American market after having received approval to market it from the US Food and Drug Administration, according to a statement by Lupin.

Trump's tariffs: How will these sectors in India be impacted?

Trump's tariffs: How will these sectors in India be impacted?

Rediff.com2 Apr 2025

Goods from sectors, including agriculture, precious stones, chemicals, pharma, medical devices, electricals, and machinery may get impacted if the US will go ahead with imposing reciprocal tariffs on Indian products, according to experts. They said that these sectors could face additional customs duties from the Trump administration because of the high tariff differential or gap, which is the difference between the import duties imposed by the US and India on a product.

Hand over central lab report to J&J: HC tells Maha

Hand over central lab report to J&J: HC tells Maha

Rediff.com27 Oct 2022

A vacation bench of Justices NJ Jamadar and Sharmila Deshmukh passed the decision on Wednesday while hearing a petition filed by the company challenging two orders of the state government.

US Justice Dept demands drug pricing info from Ranbaxy

US Justice Dept demands drug pricing info from Ranbaxy

Rediff.com17 Sep 2014

The company has received a Civil Investigative Demand from the US Department of Justice, Ranbaxy Laboratories said in a filing to the BSE.

Sterilisation botch-up: FDA seals drug unit in Raipur

Sterilisation botch-up: FDA seals drug unit in Raipur

Rediff.com13 Nov 2014

The drug controlling authority in Chhattisgarh on Thursday raided and sealed a unit of an antibiotic manufacturing company, whose product was used in sterilisation camps in Bilaspur district where 13 women died and several others fell ill.

'Real growth and opportunity are going to come from GLP-1'

'Real growth and opportunity are going to come from GLP-1'

Rediff.com21 Aug 2024

'It is not just the US and European opportunity, but it is a huge global opportunity.'

USTR Report Intensifies Trade Tensions With India

USTR Report Intensifies Trade Tensions With India

Rediff.com2 Apr 2025

The US Trade Representative noted that India's average applied tariff rate stood at 17% per cent, the highest of any major world economy.

US FDA warns against side effects of malaria drug

US FDA warns against side effects of malaria drug

Rediff.com25 Apr 2020

FDA said as of now it has issued an emergency use authorisation to allow hydroxychloroquine and chloroquine products donated to the Strategic National Stockpile to be distributed.

Ranbaxy shares jump on drug approval in US

Ranbaxy shares jump on drug approval in US

Rediff.com27 Jun 2014

Earlier in April, Sun Pharmaceuticals Industries announced acquisition of Ranbaxy in an all-share deal.

USFDA raises concern over drug production process at Cadila

USFDA raises concern over drug production process at Cadila

Rediff.com31 Jul 2014

Sources say FDA letter over product and not entire facility

Sun Pharma settles litigation with Novartis over cancer drug

Sun Pharma settles litigation with Novartis over cancer drug

Rediff.com15 May 2014

One of the subsidiaries of Sun Pharma has executed a settlement agreement with Novartis, stipulating a dismissal of the lawsuits filed in the United States against the company regarding submission of an Abbreviated New Drug Application for a generic version of Gleevec, the Indian drug major said in a statement.

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Rediff.com13 Jun 2016

The combined sales of the branded versions of the products in the US is about $3.5 billion.

Be a good neighbour, don't stoke fire of hatred: Manipur slams Mizoram CM

Be a good neighbour, don't stoke fire of hatred: Manipur slams Mizoram CM

Rediff.com30 Nov 2024

The Manipur government has accused Mizoram Chief Minister Lalduhoma of stoking hatred and division through "unwarranted comments" and called on him to display "better statesmanship" by being a "good neighbour". In a statement, the Manipur government alleged that Lalduhoma's comments were part of a "greater agenda" to carve out a Kuki-Chin Christian nation from contiguous areas of Myanmar, India, and Bangladesh. It also warned against any attempt to "push" illegal Kuki-Chin immigrants from Mizoram into Manipur for land grabbing and the creation of a "Greater Mizoram." The Mizoram government could not be reached immediately for comment.

US regulator fast-tracks approval for Wockhardt drugs

US regulator fast-tracks approval for Wockhardt drugs

Rediff.com1 Sep 2014

These drugs will be entering in their global Phase -3 clinical trials early next year.

Maha cancels Johnson & Johnson's baby powder manufacturing licence

Maha cancels Johnson & Johnson's baby powder manufacturing licence

Rediff.com17 Sep 2022

Samples of the powder for babies did not conform to standard pH value during a laboratory test, the regulator said.

Want To Invest In Pharma & Healthcare?

Want To Invest In Pharma & Healthcare?

Rediff.com5 Nov 2024

'A long-term investor with a 4 to 5 year horizon could invest in this theme via SIPs.'

Madhuri Dixit gets FDA notice for endorsing Maggi

Madhuri Dixit gets FDA notice for endorsing Maggi

Rediff.com29 May 2015

If the actress fails to respond to the notice within the stipulated time frame, a case could be registered against her, Food Security Officer Mahimanand Joshi said.

Wockhardt to recall some drugs made in India

Wockhardt to recall some drugs made in India

Rediff.com28 Apr 2015

Wockhardt is recalling select drugs in the US, which were under import restrictions from the USFDA.